Ab Science SA (ABS.PA)

ABS.PA on Paris Stock Exchange

5:40am EDT
Price Change (% chg)

€0.07 (+0.68%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ABS.PA


AB Science SA is a France-based pharmaceutical company specialized in the research, discovery, development and marketing of protein kinase inhibitors (PKIs). It is cpecialized in tageted therapies through tyrosine kinase inhibitors for treating diseases with high medical in the field of cancers, chronic inflammatory diseases,... (more)


Beta: 0.95
Market Cap (Mil.): €336.82
Shares Outstanding (Mil.): 32.93
Dividend: --
Yield (%): --


  ABS.PA Industry Sector
P/E (TTM): -- 35.07 35.49
EPS (TTM): -0.45 -- --
ROI: -56.93 18.94 18.21
ROE: -557.67 19.73 19.11
Search Stocks

AB Science loses appeal over EU rejection of cancer drug

LONDON - French biotech company AB Science has lost an appeal to get the London-based European Medicines Agency to reconsider its rejection of the company's cancer drug Masican, originally handed down in November.

21 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks